Area of research
Infectious Diseases · Fluid Flow and Transfer Processes
Research interest
Research interests include Ribavirin, Dasabuvir, Ombitasvir, Paritaprevir, Ritonavir, and Virology.
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection
Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1
Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy